However, the SURMOUNT-5 trial compared tirzepatide to semaglutide 2.4mg (a more potent GLP-1 agonist than liraglutide), and tirzepatide still showed superior weight loss: 20.2% vs 13.7% at 72 weeks
HistoIndexs AI-based fibrosis assessment uses advanced digital pathology techniques to provide detailed and precise analysis of liver tissue, helping to better understand fibrosis dynamics and treatment responses
These findings support the preventive and therapeutic potential of pomegranate juice in cancer management (364)
Hygiene Essentials Practicing good hygiene is essential
Together these data suggest that RYGB shifts the balance of the incretin effect toward GLP-1 and away from GIP
Learn more: To view or add a comment, sign in 1,657 followers Explore related topics Trends in Glp-1 Treatment Options Trends in Weight Loss Drug Accessibility Impact of Glp-1 Medications on Health How New Techniques Improve Patient Outcomes Advancements in Diabetes and Obesity Treatments How Glp-1 Drugs Impact Economic Trends Trends in Weight Management Solutions How to Align Innovation with Patient Needs Latest Strategies for Diabetes Management Latest Developments in Type 1 Diabetes Research